AMPK |
AMP-activated protein kinase |
Apaf-1 |
protease activating factor-1 |
Apo2L |
Apo-2 ligand |
ATG |
autophagy-related genes |
Bak |
Bcl-2 antagonist or killer |
Bax |
Bcl-2-associated X protein |
Bcl-2 |
B-cell CLL/lymphoma 2 |
Bcl-xL |
B-cell lymphoma-extra-large |
BH |
Bcl-2 homology |
Bid |
BH3-only protein |
BIR |
baculovirus IAP repeat |
CLL |
chronic lymphocytic leukemia |
CTC |
circulating tumour cells |
c-FLIP |
cellular (FADD-like IL-1β-converting enzyme)-inhibitory protein |
c-FLIPL
|
c-FLIP large |
c-FLIPS
|
c-FLIP short |
cIAP |
cellular inhibitor of apoptosis protein |
CPT |
circularly permuted TRAIL |
DcR |
decoy receptor |
DD |
death domain |
DED |
death effector domains |
DISC |
death-inducing signalling complex |
DLT |
dose-limiting toxicity |
DR |
death receptor |
ERK |
extracellular signal-regulated kinases |
FADD |
Fas-associated death domain |
FAP |
fibroblast-activation protein |
Fc |
fragment crystallizable region |
FDA |
United States Food and Drug Administration |
FLICE |
FADD-like IL-1β-converting enzyme |
FOLFIRI |
folinic acid, fluorouracil, irinotecan |
GALNT14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
GPI |
glycosylphosphatidylinositol |
HCC |
hepatocellular carcinoma |
HSA |
human serum albumin |
HTS |
high-throughput screenings |
IgG |
Immunoglobulin G |
IKK |
inhibitor of κB kinase |
IL |
interleukin |
iz |
isoleucin |
IκB |
inhibitor of κB |
JNK |
c-Jun N-terminal kinases |
KRAS |
Kirsten rat sarcoma |
LUBAC |
linear ubiquitin chain assembly complex |
LZ |
leucine zipper |
MAPK |
mitogen-activated protein kinase |
Mcl-1 |
myeloid leukaemia cell differentiation protein |
miRNA |
microRNA |
MOM |
mitochondrial outer membrane |
MOMP |
mitochondrial outer membrane permeabilization |
MPD |
membrane-proximal domain |
MTD |
maximum tolerated dose |
mTOR |
mechanistic target of rapamycin |
NEMO |
NF-κB essential modifier |
NF-κB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
NIAP |
neuronal apoptosis inhibitory protein |
NSCLC |
non-small-cell lung cancer |
OPG |
osteoprotegerin |
ORR |
objective response rate |
OS |
overall survival |
PFS |
progression-free survival |
pI |
isoelectric point |
PI3K |
tyrosine kinase Src and phosphoinositide 3-kinase |
PUMA |
p53 upregulated modulator of apoptosis |
Rac1 |
Ras-related C3 botulinum toxin substrate 1 |
rhTRAIL |
recombinant human TRAIL |
RIPK |
receptor-interacting protein kinase |
RRMM |
relapsed refractory multiple myeloma |
scTRAIL |
single-chain TRAIL |
SMAC/DIABLO |
second mitochondrial activator of caspases/direct inhibitor of apoptosis-binding protein with low pI |
SR |
superfamily |
tBID |
truncated BH3-only protein |
TD |
thalidomide/dexamethasone |
TNF |
tumor necrosis factor |
TNF-SF |
TNF-superfamily |
TRAF2 |
TNF receptor-associated factor-2 |
TRAE |
treatment-related adverse events |
TRAIL |
TNF-related apoptosis-inducing ligand |
TRAIL-R |
TRAIL receptor |
TRA |
TRAIL receptor agonist |
Ts-IAP |
testis-specific IAP |
USP8 |
ubiquitin-specific peptidase 8 |
VHH |
high-affinity heavy chain domain |
XIAP |
X-linked inhibitor of apoptosis protein |